None
Quote | Applied Therapeutics Inc. (NYSE:APLT)
Last: | $ |
---|---|
Change Percent: | -0.38% |
Open: | $52.94 |
Close: | $52.80 |
High: | $54.00 |
Low: | $51.52 |
Volume: | 114,734 |
Last Trade Date Time: | 02/12/2020 04:42:20 pm |
News | Applied Therapeutics Inc. (NYSE:APLT)
2024-04-22 11:18:39 ET Summary The Simplify Propel Opportunities ETF (SURI) is a healthcare-based fund that provides exposure to global fixed income and equity markets in the healthcare sector. SURI has a since-inception return of -13%, but its recent performance has shown potenti...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the appointment of Dale ...
Message Board Posts | Applied Therapeutics Inc. (NYSE:APLT)
Subject | By | Source | When |
---|---|---|---|
Looks pretty positive | 81vette | investorshub | 04/27/2023 8:51:09 PM |
$APLT here we go bulls news is here | 81vette | investorshub | 04/27/2023 2:37:32 AM |
$APLT Price trading last trade up | 81vette | investorshub | 04/26/2023 2:00:55 PM |
When is this gonna take off? | 81vette | investorshub | 04/24/2023 2:10:27 PM |
$APLT short squeeze signal | 81vette | investorshub | 04/22/2023 7:17:35 PM |
News, Short Squeeze, Breakout and More Instantly...
Applied Therapeutics Inc. Company Name:
APLT Stock Symbol:
NYSE Market:
Applied Therapeutics Inc. Website:
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company developing a p...
NEW YORK, April 15, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today announced the appointment of Dale ...
2024-04-07 03:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...